TY - JOUR
T1 - Prognostic Features in Intermediate-Size Supraglottic Tumors Treated With Open Supraglottic Laryngectomy
AU - Damiani, Marialessia
AU - Mercante, Giuseppe
AU - Abdellaoui, Mohammed
AU - Guerlain, Joanne
AU - Moya-Plana, Antoine
AU - Casiraghi, Odile
AU - Temam, Stéphane
AU - Tao, Yungan
AU - Gorphe, Philippe
N1 - Publisher Copyright:
© 2021 The American Laryngological, Rhinological and Otological Society, Inc.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Objectives/Hypothesis: We investigated growth patterns and pathological features in intermediate-size laryngeal carcinoma amenable to supraglottic laryngectomy. Study design: Retrospective cohort study. Methods: We reviewed patients who underwent an open partial horizontal laryngectomy (OPHL) type I. We analyzed pathological data, tumor sizes, overall survival, disease-specific survival, local control, and laryngeal preservation. Results were stratified between three groups: group I comprised patients with endolaryngeal carcinoma, group II comprised patients with anterior epilaryngeal carcinoma who underwent an OPHL type I + base of tongue (BOT), group III comprised patients with lateral epilaryngeal carcinoma who underwent an OPHL type I + pyriform sinus (PIR). Results: Sixty-eight patients were analyzed. The 5-year rates of overall survival, disease-specific survival, local control, and laryngeal preservation were 68.4%, 83.7%, 91.6%, and 98.3%, respectively. The tumor sizes at pathological examination were similar between the three groups (mean 27 mm, P =.80) and were associated with pathological features, notably pre-epiglottic space (PES) invasion (24.9 mm vs. 32.2 mm, P =.01), occult invaded lymph nodes (22.6 mm vs. 29.9 mm, P =.03), and trends for margins status (26.5 mm vs. 29.3 mm, P =.45). The risks of PES invasion, occult lymph nodes, and positive margins, respectively, predominated in group I (41.7%), group II (56.3%), and group III (23.3%). Conclusion: In intermediate-size tumors amenable to supraglottic laryngectomy, pathological features are associated with tumor size according to group stratification based on tumor location. Level of Evidence: 4 Laryngoscope, 131:E1980–E1986, 2021.
AB - Objectives/Hypothesis: We investigated growth patterns and pathological features in intermediate-size laryngeal carcinoma amenable to supraglottic laryngectomy. Study design: Retrospective cohort study. Methods: We reviewed patients who underwent an open partial horizontal laryngectomy (OPHL) type I. We analyzed pathological data, tumor sizes, overall survival, disease-specific survival, local control, and laryngeal preservation. Results were stratified between three groups: group I comprised patients with endolaryngeal carcinoma, group II comprised patients with anterior epilaryngeal carcinoma who underwent an OPHL type I + base of tongue (BOT), group III comprised patients with lateral epilaryngeal carcinoma who underwent an OPHL type I + pyriform sinus (PIR). Results: Sixty-eight patients were analyzed. The 5-year rates of overall survival, disease-specific survival, local control, and laryngeal preservation were 68.4%, 83.7%, 91.6%, and 98.3%, respectively. The tumor sizes at pathological examination were similar between the three groups (mean 27 mm, P =.80) and were associated with pathological features, notably pre-epiglottic space (PES) invasion (24.9 mm vs. 32.2 mm, P =.01), occult invaded lymph nodes (22.6 mm vs. 29.9 mm, P =.03), and trends for margins status (26.5 mm vs. 29.3 mm, P =.45). The risks of PES invasion, occult lymph nodes, and positive margins, respectively, predominated in group I (41.7%), group II (56.3%), and group III (23.3%). Conclusion: In intermediate-size tumors amenable to supraglottic laryngectomy, pathological features are associated with tumor size according to group stratification based on tumor location. Level of Evidence: 4 Laryngoscope, 131:E1980–E1986, 2021.
KW - Supraglottic carcinoma
KW - adverse pathological features
KW - open partial horizontal laryngectomy type I
KW - supraglottic laryngectomy
KW - tumor size
UR - http://www.scopus.com/inward/record.url?scp=85099198736&partnerID=8YFLogxK
U2 - 10.1002/lary.29367
DO - 10.1002/lary.29367
M3 - Article
C2 - 33399237
AN - SCOPUS:85099198736
SN - 0023-852X
VL - 131
SP - E1980-E1986
JO - Laryngoscope
JF - Laryngoscope
IS - 6
ER -